COPPOLA, Nicola
 Distribuzione geografica
Continente #
EU - Europa 26.819
NA - Nord America 13.351
AS - Asia 11.417
SA - Sud America 1.966
AF - Africa 178
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 8
Totale 53.748
Nazione #
RU - Federazione Russa 18.130
US - Stati Uniti d'America 13.113
SG - Singapore 4.119
IE - Irlanda 3.075
CN - Cina 2.132
HK - Hong Kong 1.987
BR - Brasile 1.657
VN - Vietnam 1.362
IT - Italia 1.342
UA - Ucraina 981
GB - Regno Unito 944
DE - Germania 922
KR - Corea 462
IN - India 338
JP - Giappone 334
FI - Finlandia 314
GR - Grecia 250
TR - Turchia 248
SE - Svezia 233
FR - Francia 192
AR - Argentina 131
CA - Canada 113
BD - Bangladesh 91
AT - Austria 84
NL - Olanda 80
IQ - Iraq 67
MX - Messico 62
PL - Polonia 57
ZA - Sudafrica 54
EC - Ecuador 48
BE - Belgio 46
PK - Pakistan 40
ID - Indonesia 36
CO - Colombia 34
ES - Italia 33
CZ - Repubblica Ceca 28
MA - Marocco 25
RS - Serbia 22
EG - Egitto 21
UZ - Uzbekistan 21
PE - Perù 20
VE - Venezuela 20
PY - Paraguay 18
CL - Cile 16
IR - Iran 16
DZ - Algeria 15
LT - Lituania 14
AZ - Azerbaigian 13
TN - Tunisia 13
AE - Emirati Arabi Uniti 12
JO - Giordania 12
KZ - Kazakistan 12
BO - Bolivia 11
TW - Taiwan 11
HN - Honduras 10
IL - Israele 10
KE - Kenya 10
PH - Filippine 10
TT - Trinidad e Tobago 10
UY - Uruguay 10
AL - Albania 9
DO - Repubblica Dominicana 9
EU - Europa 9
JM - Giamaica 9
MY - Malesia 9
SA - Arabia Saudita 9
CH - Svizzera 8
DK - Danimarca 8
KG - Kirghizistan 8
NP - Nepal 8
RO - Romania 8
SN - Senegal 8
ET - Etiopia 7
GE - Georgia 7
LB - Libano 7
CR - Costa Rica 6
MK - Macedonia 6
PA - Panama 6
PT - Portogallo 6
AM - Armenia 5
SY - Repubblica araba siriana 5
AU - Australia 4
BG - Bulgaria 4
HU - Ungheria 4
LV - Lettonia 4
NG - Nigeria 4
NI - Nicaragua 4
PS - Palestinian Territory 4
QA - Qatar 4
BB - Barbados 3
BN - Brunei Darussalam 3
CM - Camerun 3
EE - Estonia 3
GA - Gabon 3
NZ - Nuova Zelanda 3
OM - Oman 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
BA - Bosnia-Erzegovina 2
BF - Burkina Faso 2
Totale 53.711
Città #
Moscow 6.590
Dublin 3.073
Hong Kong 1.972
Singapore 1.710
Santa Clara 1.681
Jacksonville 1.481
San Jose 1.306
Chandler 988
Ashburn 661
Chicago 561
Wilmington 546
Ho Chi Minh City 465
Seoul 460
Princeton 407
Falls Church 345
Hanoi 341
Roxbury 315
Bremen 309
Hefei 306
Beijing 279
New York 262
Dallas 227
Ann Arbor 221
Medford 212
Cambridge 207
Caserta 203
Bengaluru 199
The Dalles 198
Naples 183
Boardman 156
São Paulo 139
Los Angeles 133
Munich 128
Woodbridge 111
Da Nang 100
San Mateo 99
Houston 98
Des Moines 90
Memphis 76
Orem 74
Nuremberg 61
Council Bluffs 56
Helsinki 51
Jinan 51
Mountain View 50
Rome 49
Amsterdam 48
Aversa 48
Haiphong 48
Milan 48
Rio de Janeiro 48
Chennai 46
Nanjing 46
Brussels 44
Brasília 43
Napoli 43
Washington 43
Vienna 41
Frankfurt am Main 40
London 38
Düsseldorf 37
Warsaw 36
Tokyo 35
Belo Horizonte 31
Guangzhou 31
Montreal 31
Istanbul 30
Manchester 29
Atlanta 28
Auburn Hills 28
Tianjin 28
Hangzhou 27
Porto Alegre 27
Biên Hòa 25
Campinas 25
Hải Dương 25
Paris 25
Phoenix 25
Shenyang 25
Curitiba 24
Hillsboro 24
Marano 24
Shanghai 24
Toronto 24
Brno 23
San Francisco 23
Falkenstein 22
Johannesburg 22
Baghdad 21
Brooklyn 21
Nanchang 21
Turku 21
Boston 20
Giugliano in Campania 20
Mumbai 20
Ninh Bình 20
Norwalk 20
Stockholm 20
Tashkent 20
Thái Bình 20
Totale 28.856
Nome #
The role of bacterial colonization of the suture thread in early identification and targeted antibiotic treatment of surgical site infections: A prospective cohort study 1.381
Anticoagulant treatment in COVID-19: a narrative review 208
Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C 206
Cannabinoid receptor 2-63 QQ varianti s associated with severe necroinflammation in chronic epatiti C 205
Application and internal validation of lung ultrasound score in COVID-19 setting: The ECOVITA observational study 198
Association Between a Polymorphism in Cannabinoid Receptor 2 and Severe Necroinflammation in Patients With Chronic Hepatitis C. 191
Functional interplay between hepatitis B virus X protein and human miR-125a in HBV infection 190
Diagnosis and clinical impact of occult hepatitis B infection in patients with biopsy proven hepatitis C: a multicenter study 188
Does poor glycaemic control affect the immunogenicity of the COVID-19 vaccination in patients with type 2 diabetes: The CAVEAT study 186
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 183
Liver microRNA hsa-miR-125a-5p in HBV Chronic Infection: Correlation with HBV Replication and Disease Progression 183
Non-invasive respiratory support in SARS-CoV-2 related acute respiratory distress syndrome: when is it most appropriate to start treatment? 182
Prevalence and associated risk factors of latent tuberculosis infection among undergraduate and postgraduate dental students: A retrospective study 182
A case report of a severe fluoropyrimidine-related toxicity due to an uncommon DPYD variant 182
Cannabinoid receptor 2-63 QQ variant is associated with persistently normal aminotransferase serum levels in chronic hepatitis C 181
Characteristics of liver cirrhosis in Italy: Evidence for a decreasing role of HCV aetiology. 179
Acute hepatitis with severe cholestasis and prolonged clinical course due to hepatitis A virus Ia and Ib coinfection 176
Cannabinoid Receptor 2 (CB2) Q63 variant in chronic hepatitis C: an association with a more severe hepatocellular necrosis. 176
Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration 175
Vaccination against hepatitis b virus: Are Italian medical students sufficiently protected after the public vaccination programme? 173
Erratum: Vaccination against hepatitis b virus: Are Italian medical students sufficiently protected after the public vaccination programme (Journal of Occupational Medicine and Toxicology (2015) 10:41) 171
CB2-63 polymorphism and immune-mediated diseases associated with HCV chronic infection. 170
(INVITED)Quantitative detection of SARS-CoV-2 virions in aqueous mediums by IoT optical fiber sensors 169
Micro-RNAs in hepatitis B virus-related chronic liver diseases and hepatocellular carcinoma 167
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort 166
Abstracts of the 63rd Annual Meeting of the American Association for the Study of Liver Diseases. November 9-13, 2012. Boston, Massachusetts, USA. 166
Epidemiology of HCV and HBV in a High Endemic Area of Southern Italy: Opportunities from the COVID-19 Pandemic—Standardized National Screening or One Tailored to Local Epidemiology? 165
An attempt to improve classification of HCV-correlated chronic hepatitis 164
733 REACTIVATION OF OVERT AND OCCULT HBV INFECTION IN IMMUNOSUPPRESSIVE SETTINGS Journal of Hepatology 163
Absence of occult HCV infection in patients experiencing an immunodepression condition 163
Current Views on Infective Endocarditis: Changing Epidemiology, Improving Diagnostic Tools and Centering the Patient for Up-to-Date Management 163
Biochemical predictors of diabetic foot osteomyelitis: A potential diagnostic role for parathormone 162
Abacavir hypersensivity reaction (HSR), associated to baseline false negative HLAB5701 screening, in antiretroviral treatment naive HIV-1 patient. 162
Humoral response and safety of the third booster dose of BNT162b2 mRNA COVID-19 vaccine in patients with multiple sclerosis treated with ocrelizumab or fingolimod 161
Cannabinoid receptor 2 (CB2) Q63 variant is associated with a severe histological activity index in patients with chronic hepatitis C 161
Blood-borne chronic viral infections in a large cohort of immigrants in southern Italy: A seven-centre, prospective, screening study 161
Association between anti-HBc positivity and hepatocellular carcinoma in HBsAg-negative subjects with chronic liver disease: A meta-analysis 160
Cannabinoid receptor 2-63 RR variant is independently associated with severe necroinflammation in HIV/HCV coinfected patients. 160
Lowered expression of microRNA-125a-5p in human hepatocellular carcinoma and up-regulation of its oncogenic targets sirtuin-7, matrix metalloproteinase-11, and c-Raf 159
Eighteen-month lamivudine prophylaxis on preventing occult hepatitis B virus infection reactivation in patients with haematological malignancies receiving immunosuppression therapy 158
HBV vaccination status among healthcare workers: A cross-sectional study 158
964 HBV occult infection in patients with chronic hepatitis C: a multicentric prospective study 157
Patologie virali tropicali (Flavivirus, Filovirus, Arenavirus, Bunyavirus, Togavirus: Chikungunya, 156
Correlation between the hepatic expression of human microRNA hsa-miR-125a-5p and the progression of fibrosis in patients with overt and occult HBV infection 155
Mortality and risk factors of vaccinated and unvaccinated COVID-19 frail patients treated with anti-SARS-CoV-2 monoclonal antibodies. A real-world study 154
Antibiotic resistance in diabetic foot infection: how it changed with COVID-19 pandemic in a tertiary care center 154
Epidemiological, Clinical and Microbiological Characteristics of Patients with Bloodstream Infections Due to Carbapenem-Resistant K. Pneumoniae in Southern Italy: A Multicentre Study 153
Adherence to Barcelona Clinic Liver Cancer guidelines in field practice: Results of Progetto Epatocarcinoma Campania 152
The aetiology of chronic hepatitis in Italy: results from a multicentre national study 151
416 molecular analysis of genetic variability and epitope stability in a type 1B recurrent HCV infection 151
Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infection in undocumented migrants and refugees in southern Italy, January 2012 to June 2013 151
Real-life glecaprevir/pibrentasvir in a large cohort of patients with hepatitis C virus infection: The MISTRAL study 151
Secondary Complications in COVID-19 Patients: A Case Series 150
Acute hepatitis C: clinical and laboratory diagnosis, course of the disease, treatment 150
Clinical findings of HCV chronic infection in undocumented immigrants and low-income refugees in three areas of southern Italy 150
Characteristics of patients with hepatitis C virus-related chronic liver diseases just before the era of oral direct-acting antiviral therapy in Italy. 150
Cardiovascular system in COVID-19: Simply a viewer or a leading actor? 150
The impact of the CB2-63 polymorphism on the histological presentation of chronic hepatitis B. 149
Impact of comorbidities on the severity of chronic hepatitis B at presentation 149
579 CHANGING PATTERN OF HBV GENOTYPES IN ITALY 149
540 IDENTIFICATION OF LAMIVUDINE RESISTANT HBV STRAIN RT204V/I IN ACUTE HEPATITIS B IN ITALY 149
Efficacy and safety of tixagevimab-cilgavimab (Evusheld®) in people with Multiple Sclerosis on Ocrelizumab: preliminary evidence 148
Prevalence of latent tuberculosis infection and associated risk factors among 3,374 healthcare students in Italy 148
Absence of occult HCV infection in HIV-positive patients 144
Humoral response to SARS-CoV-2 mRNA vaccine in patients with multiple sclerosis treated with natalizumab 144
A structural equation model to examine the clinical features of mild-to-moderate COVID-19: A multicenter Italian study 143
Delirium and Psychiatric Sequelae Associated to SARS-CoV-2 in Asymptomatic Patients With Psychiatric History and Mild Cognitive Impairment as Risk Factors: Three Case Reports 142
Recommendations for the management of acute hepatitis B: position paper of the italian Society for the study of infectious and tropical diseases 141
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 141
Hyperglycaemia on admission to hospital and COVID-19 141
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 140
Six-month humoral response to mRNA SARS-CoV-2 vaccination in patients with multiple sclerosis treated with ocrelizumab and fingolimod 140
[639] ANTIVIRAL TREATMENT IN CHRONIC HBV/HCV COINFECTION: VIROLOGICAL CHANGES IN THREE COMPARTMENTS (PLASMA, PBMC AND LIVER TISSUE) AND CLINICAL OUTCOME 139
Efficacy of Unsupervised Self-Collected Mid-Turbinate FLOQSwabs for the Diagnosis of Coronavirus Disease 2019 (COVID-19) 138
Lactate dehydrogenase and PaO2/FiO2 ratio at admission helps to predict CT score in patients with COVID-19: An observational study 138
Clinical and virological characteristics associated with severe acute hepatitis B 138
Liver microRNA hsa-miR-125a-5p may exert an oncosuppressor effect on hepatocellular carcinoma (HCC). 138
Acute hepatitis C: Clinical and laboratory diagnosis, course of the disease, treatment 138
Risk and prevention of hepatitis b virus reactivation during immunosuppression for non-oncological diseases 138
An Unusual Case of a Double Tricuspid and Mitral Valves Infective Endocarditis Complicated by Multiple Septic Embolisms Secondary to an Atrial Septal Defect: A Case Report and Review of Literature 137
4. Infezioni da Salmonelle non-tifoidee: nuovi aspetti epidemiologici 137
Absence of Helicobacter spp in the liver of patients with primary or metastatic liver cancer 137
Clinical significance of hepatitis B surface antigen mutants 137
Impact of PNPLA3 variants on liver histology of 168 patients with HIV infection and chronic hepatitis C. 137
Hepatitis B virus infection in undocumented immigrants and refugees in Southern Italy: demographic, virological, and clinical features 137
ACUTE EXACERBATION OF CHRONIC HEPATITIS C: CLINICAL PRESENTATION, OUTCOME AND RESPONSE TO ANTI-HCV TREATMENT 137
Virological patterns of HCV patients with failure to interferon-free regimens. 136
A hyper-glycosilation of HBV surface major hydrophilic correlates with immunosuppression-driven HBV reactivation and hampers HBsAg recognition in vitro 136
Preliminary evidence of blunted humoral response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients treated with ocrelizumab 136
Six-month humoral response to BNT162b2 mRNA COVID-19 vaccine in people with multiple sclerosis treated with natalizumab 136
[Virological and clinical aspects of multiple hepatitis virus infections: preliminary data of an italian multicentre study] 135
A hyper-glycosilation of HBV surface major hydrophilic region characterizes HBV reactivation driven by immunosuppression and affects HBsAg recognition in vitro 135
PNPLA3 l148M variant as a risk factor for carotid atherosclerosis in chronic epatiti C 134
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens. 134
An estimation of the prevalence of occult HBV infection in Western Europe and in Northern America: A meta-analysis 134
A HIGH HBSAG GENETIC COMPLEXITY CAN INFLUENCE HBV IMMUNOGENICITY IN THE SETTING OF ACUTE INFECTION 134
Directly acting antiviral-based treatment for hcv-infected persons who inject drugs: A multicenter real-life study 134
Anti-HCV IgG avidity index in acute hepatitis C. 133
The long-term immunogenicity of recombinant hepatitis B virus (HBV) vaccine: Contribution of universal HBV vaccination in Italy 133
The TM6SF2 E167K variant in HIV/HCV coinfection predicts severe liver fibrosis and, only for patients with HCV genotype non 3 severe steatosis. 133
Totale 16.766
Categoria #
all - tutte 190.651
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 190.651


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202142 0 0 0 0 0 0 0 0 0 0 0 42
2021/20223.202 179 157 255 124 802 61 154 63 100 240 224 843
2022/20235.509 544 176 369 298 620 320 10 241 2.710 34 101 86
2023/20242.308 177 82 131 177 815 242 30 62 26 32 143 391
2024/20257.633 49 87 54 195 1.142 1.016 1.061 680 1.161 1.160 605 423
2025/202630.117 1.164 1.467 1.486 1.435 2.531 16.800 1.575 990 1.180 688 526 275
Totale 54.643